gabexate has been researched along with Cerebral Infarction in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nomoto, Y | 1 |
| Hirose, Y | 1 |
| Tanaka, T | 1 |
| Kinoshita, H | 1 |
| Yamazaki, Y | 1 |
1 other study available for gabexate and Cerebral Infarction
| Article | Year |
|---|---|
Heparin-induced thrombocytopenia, anomalous laboratory findings lead to the correct diagnosis.
Topics: Cerebral Infarction; Clinical Laboratory Techniques; Diagnosis, Differential; Follow-Up Studies; Gab | 2007 |